172 related articles for article (PubMed ID: 34492627)
21. Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in patients with breast cancer?
Wu LM; Hu JN; Gu HY; Hua J; Chen J; Xu JR
Breast Cancer Res Treat; 2012 Aug; 135(1):17-28. PubMed ID: 22476850
[TBL] [Abstract][Full Text] [Related]
22. Potential of Noncontrast Magnetic Resonance Imaging With Diffusion-Weighted Imaging in Characterization of Breast Lesions: Intraindividual Comparison With Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
Baltzer PAT; Bickel H; Spick C; Wengert G; Woitek R; Kapetas P; Clauser P; Helbich TH; Pinker K
Invest Radiol; 2018 Apr; 53(4):229-235. PubMed ID: 29190227
[TBL] [Abstract][Full Text] [Related]
23. The diagnostic performance of CESM and CE-MRI in evaluating the pathological response to neoadjuvant therapy in breast cancer: a systematic review and meta-analysis.
Tang S; Xiang C; Yang Q
Br J Radiol; 2020 Aug; 93(1112):20200301. PubMed ID: 32574075
[TBL] [Abstract][Full Text] [Related]
24. Meta-analysis of dynamic contrast enhancement and diffusion-weighted MRI for differentiation of benign from malignant non-mass enhancement breast lesions.
Zhang J; Li L; Zhang L; Zhe X; Tang M; Lei X; Zhang X
Front Oncol; 2024; 14():1332783. PubMed ID: 38544833
[TBL] [Abstract][Full Text] [Related]
25. FDG-PET/CT and MRI for Evaluation of Pathologic Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: A Meta-Analysis of Diagnostic Accuracy Studies.
Sheikhbahaei S; Trahan TJ; Xiao J; Taghipour M; Mena E; Connolly RM; Subramaniam RM
Oncologist; 2016 Aug; 21(8):931-9. PubMed ID: 27401897
[TBL] [Abstract][Full Text] [Related]
26. The Combination of Diffusion- and T2-Weighted Imaging in Predicting Deep Myometrial Invasion of Endometrial Cancer: A Systematic Review and Meta-Analysis.
Deng L; Wang QP; Chen X; Duan XY; Wang W; Guo YM
J Comput Assist Tomogr; 2015; 39(5):661-73. PubMed ID: 26295190
[TBL] [Abstract][Full Text] [Related]
27. Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted magnetic resonance imaging for predicting the response of locally advanced breast cancer to neoadjuvant therapy: a meta-analysis.
Virostko J; Hainline A; Kang H; Arlinghaus LR; Abramson RG; Barnes SL; Blume JD; Avery S; Patt D; Goodgame B; Yankeelov TE; Sorace AG
J Med Imaging (Bellingham); 2018 Jan; 5(1):011011. PubMed ID: 29201942
[TBL] [Abstract][Full Text] [Related]
28. MRI and PET/CT for evaluation of the pathological response to neoadjuvant chemotherapy in breast cancer: A systematic review and meta-analysis.
Li H; Yao L; Jin P; Hu L; Li X; Guo T; Yang K
Breast; 2018 Aug; 40():106-115. PubMed ID: 29758503
[TBL] [Abstract][Full Text] [Related]
29. Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.
Li T; Yu T; Li L; Lu L; Zhuo Y; Lian J; Xiong Y; Kong D; Li K
J Magn Reson Imaging; 2018 Nov; 48(5):1358-1366. PubMed ID: 29717790
[TBL] [Abstract][Full Text] [Related]
30. Diffusion-weighted imaging or dynamic contrast-enhanced curve: a retrospective analysis of contrast-enhanced magnetic resonance imaging-based differential diagnoses of benign and malignant breast lesions.
Yang X; Dong M; Li S; Chai R; Zhang Z; Li N; Zhang L
Eur Radiol; 2020 Sep; 30(9):4795-4805. PubMed ID: 32350660
[TBL] [Abstract][Full Text] [Related]
31. MRI for Assessing Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer Using DCE-MR and DW-MR Data Sets: A Preliminary Report.
Petrillo M; Fusco R; Catalano O; Sansone M; Avallone A; Delrio P; Pecori B; Tatangelo F; Petrillo A
Biomed Res Int; 2015; 2015():514740. PubMed ID: 26413528
[TBL] [Abstract][Full Text] [Related]
32. Dynamic contrast-enhanced MRI for the detection of prostate cancer: meta-analysis.
Tan CH; Hobbs BP; Wei W; Kundra V
AJR Am J Roentgenol; 2015 Apr; 204(4):W439-48. PubMed ID: 25794093
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of Breast Cancer Morphology Using Diffusion-Weighted and Dynamic Contrast-Enhanced MRI: Intermethod and Interobserver Agreement.
Radovic N; Ivanac G; Divjak E; Biondic I; Bulum A; Brkljacic B
J Magn Reson Imaging; 2019 May; 49(5):1381-1390. PubMed ID: 30325549
[TBL] [Abstract][Full Text] [Related]
34. Intratumor partitioning and texture analysis of dynamic contrast-enhanced (DCE)-MRI identifies relevant tumor subregions to predict pathological response of breast cancer to neoadjuvant chemotherapy.
Wu J; Gong G; Cui Y; Li R
J Magn Reson Imaging; 2016 Nov; 44(5):1107-1115. PubMed ID: 27080586
[TBL] [Abstract][Full Text] [Related]
35. MRI-Based Radiomics Methods for Predicting Ki-67 Expression in Breast Cancer: A Systematic Review and Meta-analysis.
Tabnak P; HajiEsmailPoor Z; Baradaran B; Pashazadeh F; Aghebati Maleki L
Acad Radiol; 2024 Mar; 31(3):763-787. PubMed ID: 37925343
[TBL] [Abstract][Full Text] [Related]
36. [Preliminary study of combining T2-weighted imaging, diffusion weighted imaging and dynamic contrast enhanced-magnetic resonance imaging for diagnosing prostatic central gland cancer].
Li P; Yang W; Chen Z; Guo Y; Cai L; Du Y; Li Y
Zhonghua Yi Xue Za Zhi; 2014 Aug; 94(31):2448-51. PubMed ID: 25400054
[TBL] [Abstract][Full Text] [Related]
37. 18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis.
Machado Medeiros T; Altmayer S; Watte G; Zanon M; Basso Dias A; Henz Concatto N; Hoefel Paes J; Mattiello R; de Souza Santos F; Mohammed TL; Verma N; Hochhegger B
Eur Radiol; 2020 Jul; 30(7):3641-3649. PubMed ID: 32125513
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic performance of diffusion-weighted (DWI) and dynamic contrast-enhanced (DCE) MRI for the differentiation of benign from malignant soft-tissue tumors.
Choi YJ; Lee IS; Song YS; Kim JI; Choi KU; Song JW
J Magn Reson Imaging; 2019 Sep; 50(3):798-809. PubMed ID: 30663160
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic performance of dynamic contrast-enhanced magnetic resonance imaging for malignant ovarian tumors: a systematic review and meta-analysis.
Wei M; Bo F; Cao H; Zhou W; Shan W; Bai G
Acta Radiol; 2021 Jul; 62(7):966-978. PubMed ID: 32741199
[TBL] [Abstract][Full Text] [Related]
40. Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC).
Abdelhafez AH; Musall BC; Adrada BE; Hess K; Son JB; Hwang KP; Candelaria RP; Santiago L; Whitman GJ; Le-Petross HT; Moseley TW; Arribas E; Lane DL; Scoggins ME; Leung JWT; Mahmoud HS; White JB; Ravenberg EE; Litton JK; Valero V; Wei P; Thompson AM; Moulder SL; Pagel MD; Ma J; Yang WT; Rauch GM
Breast Cancer Res Treat; 2021 Jan; 185(1):1-12. PubMed ID: 32920733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
